BACE2 Rabbit Polyclonal Antibody
Rabbit Polyclonal Anti-BACE2 Antibody, Purified
Product Datasheet for 'AP22930PU-N'
|Recommend Dilution||IHC, WB|
|Immunogen||BACE2 antibody was raised against synthetic peptide corresponding to amino acids near the carboxy terminus of human BACE2|
|Formulation||PBS containing 0.02% sodium azide.|
|Predicted Protein Size||49.8 kDa|
|Gene Name||beta-site APP-cleaving enzyme 2|
|Background||Accumulation of the amyloid-beta (alpha-beta) plaque in the cerebral cortex is a critical event in the pathogenesis of Alzheimer’s disease. alpha-beta peptide is generated by proteolytic cleavage of the beta-amyloid protein precursor (APP) at beta- and gamma-sites by proteases. The long-sought beta-secretase was recently identified by several groups independently and designated beta-site APP cleaving enzyme (BACE) and aspartyl protease 2 (Asp2) (1-4). BACE/Asp2 is a novel transmembrane aspartic protease and co-localizes with APP. A BACE homolog was recently cloned and designated BACE2, Asp1, DRAP (for Down region aspartic protease), and memapsin 1 (4-9). BACE2 also cleaves APP at b-site and at a different site within alpha-beta (8). BACE2 locates on chromosome 21q22.3, the so-called ¡®Down critical region¡¯, suggesting that BACE2 and aβ may also contribute to the pathogenesis of Down syndrome (6,7)|
|Synonyms||AEPLC; ALP56; ASP1; ASP21; BAE2; CDA13; CEAP1; DRAP|
|Protein Families||Druggable Genome, Protease, Transmembrane|
|Protein Pathways||Alzheimer's disease|
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.